Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer

NCT04921527 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

454

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Relapsed or Refractory
Chiauranib
Paclitaxel

Interventions

DRUG: chiauranib
DRUG: Placebo
DRUG: Paclitaxel

Sponsor

Chipscreen Biosciences, Ltd.